Skip to main content
. 2020 Oct 29;890:173688. doi: 10.1016/j.ejphar.2020.173688

Table 2.

ADME/T properties of the selected compounds using Swiss-ADME online server.

ADME/T properties
S. No Compound Molecular weight (g/mol) Rotatable bonds LogP Blood brain barrier Lipinski rule of five Absorption LogS H-bond accept H-bond donor TPSA (A2) log Kp (cm/s)
1 Camostat 374.4 6 0.31 No 0 Low −4.22 3 4 115.56 −6.43
2 Columbin 392.5 4 3.37 No 0 Low −4.14 4 3 162.88 −6.64
3 Meloxicam 443.41 6 2.68 No 0 Low −4.61 4 4 141.85 −6.94
4 Myricetin 409.31 6 −2.85 No 1 Low −4.31 3 5 123.7 −6.7
5 Ganodermanontriol 380.79 5 2.8 No 0 Low −4.89 3 5 157.83 −5.07
6 Nafamostat 419.68 4 2.8 No 1 Low −4.12 3 4 150.7 −5.23
7 Proanthocyanidin A2 576.50 2 1.61 No 3 Low −6.44 12 9 209.76 −8.12
8 Baicalein 446.36 4 0.22 No 2 Low −4.63 11 6 187.12 −8.23
9 Jatrorrhizine 338.38 3 2.31 Yes 0 High −4.19 4 1 51.80 −5.94
ADME/T properties
S. No Compound Lead-likeness CYP1A2 inhibitor CYP2C19 inhibitor CYP2C9 inhibitor CYP2D6 inhibitor CYP3A4 inhibitor ESOL Solubility (mg/ml) Bioavailability Synthetic accessibility
1 Camostat 1 No No No No No 2.35E-02 0.55 2.83
2 Columbin 1 No No No No No 2.87E-02 0.55 4.17
3 Meloxicam 1 No No No No No 1.09E-02 0.55 3.79
4 Myricetin 1 No No No No No 2.02E-02 0.55 3.44
5 Ganodermanontriol 1 No No No No No 2.86E-03 0.17 3.43
6 Nafamostat 1 No No No No No 3.92E-02 0.55 5.41
7 Proanthocyanidin A2 1 No No Yes No No −5.21 0.17 5.85
8 Baicalein 1 No No No No No −3.41 0.11 5.09
9 Jatrorrhizine 1 Yes No No Yes Yes −4.37 0.55 3.06

Minimal Ranges: MW = Molecular Weight (130.0/725.0), Rotor = No. of Rotatable Bonds (0.0/15.0), logP o/w = log P for octanol/water (−2.0/6.5), logBB = log BB for brain/blood (Low), logS = log S for aqueous solubility (−6.5/0.5), % Human Oral Absorption in GI (High), Lipinski Rule of 5 Violations (maximum is 4), accPthB = Acceptor - Hydrogen Bonds (2.0/20.0), donorHB = Donor - Hydrogen Bonds (0.0/6.0), log Kp = log Kp for skin permeability (Kp in cm/s), TPSA = topological polar surface area (0.0/450.0), ESOL = Estimated SOLubility (−2.78/10.0), Bioavailability=(0.00/0.55), Synthetic accessibility=(2.0/3.0).